| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 11.93 Billion | USD 17.32 Billion | 3.8% | 2024 |
FrequentlyAsked Questions
The global general anxiety disorder treatment market is expected to grow due to increasing prevalence of anxiety disorders, rising mental health awareness, advancements in pharmacological and therapeutic treatments, and growing adoption of digital mental health solutions.
According to a study, the global general anxiety disorder treatment market size was worth around USD 11.93 Billion in 2024 and is expected to reach USD 17.32 Billion by 2034.
The global general anxiety disorder treatment market is expected to grow at a CAGR of 3.8% during the forecast period.
North America is expected to dominate the general anxiety disorder treatment market over the forecast period.
Leading players in the global general anxiety disorder treatment market include Pfizer Inc., Merck & Co. Inc., AstraZeneca, GlaxoSmithKline plc, Eli Lilly and Company, Bristol-Myers Squibb, Johnson & Johnson, and H. Lundbeck A/S, among others.
The report explores crucial aspects of the general anxiety disorder treatment market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
HappyClients